REFERENCES
- Rinaldi R C, Steindler E M, Wilford B B, Goodwin, D.. Clarification and standardization of substance abuse terminology. JAMA. 1988; 259: 555–7. [PUBMED], [INFOTRIEVE]
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, APA. 1994
- Koob G F, Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001; 24: 97–129. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adinoff B, O'Neil H K, Ballenger J C. Alcohol withdrawal and limbic kindling. Am J Addict. 1995; 4: 5–17
- Baker T B, Morse E, Sherman J E. The motivation to use drugs: a psychobiological analysis of urges. Dienstbier R A, Rivers P C, Lincoln N E. Nebraska symposium on motivation, 1986: alcohol and addictive behavior. Lincoln, University of Nebraska Press. 1986
- Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954; 47: 419–27. [PUBMED], [INFOTRIEVE]
- Heath R G. Electrical self-stimulation of the brain in man. Am J Psychiatry. 1963; 120: 571–7. [PUBMED], [INFOTRIEVE]
- Heath R G.. Pleasure and brain activity in man. Deep and surface electroencephalograms during orgasm. J Nerv Ment Dis. 1972; 154: 3–18. [PUBMED], [INFOTRIEVE]
- Baumeister A A. The Tulane Electrical Brain Stimulation Program a historical case study in medical ethics. J Hist Neurosci. 2000; 9: 262–78. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gardner E L. Brain reward mechanisms. Lowinson J H, Ruiz P, Millman R B, Langrod J G. Substance abuse: a comprehensive textbook. Baltimore, MD, Williams & Wilkins. 1997
- Gardner E L, Ashby C R, Jr.. Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology. Neurosci Biobehav Rev. 2000; 24: 115–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carlezon W A, Jr., Wise R A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci. 1996; 16: 3112–22. [PUBMED], [INFOTRIEVE]
- Fredholm B B, Svenningsson P. Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology. 2003; 61: S5–9. [PUBMED], [INFOTRIEVE]
- Wise R A. Neurobiology of addiction. Curr Opin Neurobiol. 1996; 6: 243–51. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Di, Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol. 1998; 12: 54–67. [CSA]
- Di, Chiara G.. Alcohol and dopamine. Alcohol Health Res World. 1997; 21: 108–14
- Jentsch J D, Taylor J R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl). 1999; 146: 373–90. [CSA]
- Ritz M C, Lamb R J, Goldberg S R, Kuhar M J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987; 237: 1219–23. [PUBMED], [INFOTRIEVE]
- Bunney B S, Aghajanian G K. d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn Schmiedebergs Arch Pharmacol. 1978; 304: 255–61. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Johnson S W, North R A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992; 12: 483–8. [PUBMED], [INFOTRIEVE]
- Bozarth M A, Wise R A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science. 1984; 224: 516–7. [PUBMED], [INFOTRIEVE]
- Gardner E L. What we have learned about addiction from animal models of drug self-administration. Am J Addict. 2000; 9: 285–313. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berridge K C, Robinson T E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience. Brain Res Brain Res Rev. 1998; 28: 309–69. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kelley A E, Berridge K C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002; 22: 3306–11. [PUBMED], [INFOTRIEVE]
- Pettit H O, Justice J B, Jr.. Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 1991; 539: 94–102. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bergman J, Kamien J B, Spealman R D. Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol. 1990; 1: 355–63. [PUBMED], [INFOTRIEVE]
- Davis W M, Smith S G. Effect of haloperidol on (+)-amphetamine self-administration. J Pharm Pharmacol. 1975; 27: 540–2. [PUBMED], [INFOTRIEVE]
- Caine S B, Koob G F. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J Exp Anal Behav. 1994; 61: 213–21. [PUBMED], [INFOTRIEVE], [CSA]
- Breiter H C, Gollub R L, Weisskoff R M, et al, Acute effects of cocaine on human brain activity and emotion. Neuron. 1997; 19: 591–611. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volkow N D, Wang G J, Fischman M W, et al, Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997; 386: 827–30. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N D, Wang G J, Fowler J S, et al, Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse. 1994; 16: 255–62. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dackis C A, Gold M S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev. 1985; 9: 469–77. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volkow N D, Fowler J S, Wang G J, Goldstein R Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002; 78: 610–24. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Salamone J, Cousins M, Snyder B. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev. 1997; 21: 341–59. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Malison R T, Best S E, van, Dyck C H, et al, Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998; 155: 832–4. [PUBMED], [INFOTRIEVE]
- Volkow N D, Fowler J S, Wang G-J, et al, Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993; 14: 169–77. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N D, Chang L, Wang G J, et al, Low level of brain dopamine d(2) receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001; 158: 2015–21. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thanos P K, Volkow N D, Freimuth P, et al, Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem. 2001; 78: 1094–103. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morgan D, Grant K A, Gage H D, et al, Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci. 2002; 5: 169–74. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Glick S D, Raucci J, Wang S, Keller R W, Jr, Carlson J N. Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res. 1994; 653: 148–54. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Malcolm R, Kajdasz D K, Herron J, Anton R F, Brady K T. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000; 60: 161–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shoptaw S, Kintaudi P C, Charuvastra C, Ling W. A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend. 2002; 66: 217–24. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Soares B G, Lima M S, Reisser A A, Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev. 2001, CD003352. [CSA]
- Eiler K, Schaefer M R, Salstrom D, Lowery R. Double-blind comparison of bromocriptine and placebo in cocaine withdrawal. Am J Drug Alcohol Abuse. 1995; 21: 65–79. [PUBMED], [INFOTRIEVE], [CSA]
- Handelsman L, Rosenblum A, Palij M, et al, Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict. 1997; 6: 54–64. [PUBMED], [INFOTRIEVE], [CSA]
- Grabowski J, Roache J D, Schmitz J M, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol. 1997; 17: 485–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stine S M, Krystal J H, Kosten T R, Charney D S. Mazindol treatment for cocaine dependence. Drug Alcohol Depend. 1995; 39: 245–52. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rocha B A, Fumagalli F, Gainetdinov R R, et al, Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci. 1998; 1: 132–7. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999; 22: 521–7. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Halikas J A, Kuhn K L. A possible neurophysiological basis of cocaine craving. Ann Clin Psyhiatry. 1990; 2: 79–83. [CSA]
- Post R M, Weiss S R. Psychomotor stimulant vs. local anesthetic effects of cocaine: role of behavioral sensitization and kindling. NIDA Res Monogr. 1988; 88: 217–38. [CSA]
- Robinson T E, Berridge K C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993; 18: 247–91. [PUBMED], [INFOTRIEVE], [CSA]
- Goddard G V, McIntyre D C, Leech C K. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969; 25: 295–330. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Janowsky J S, Laxer K D, Rushmer D S. Classical conditioning of kindled seizures. Epilepsia. 1980; 21: 393–8. [PUBMED], [INFOTRIEVE]
- Grode J. Ueber die wirkung langerer cocainedarrechung bei tieren. Arch F Exp Path U Pharmakol. 1912; 67: 172–9
- Zahniser N R, Peris J, Dwoskin L P, et al, Sensitization to cocaine in the nigrostriatal dopamine system. NIDA Res Monogr. 1988; 88: 55–77. [PUBMED], [INFOTRIEVE]
- Kalivas P W, Pierce R C, Cornish J, Sorg B A. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol (Oxf). 1998; 12: 49–53. [CSA]
- Self D W, Nestler E J. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 1998; 51: 49–60. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pascual-Leone A, Dhuna A, Anderson D C. Longterm neurological complications of chronic, habitual cocaine abuse. Neurotoxicology. 1991; 12: 393–400. [PUBMED], [INFOTRIEVE]
- Washton A M, Gold M S. Chronic cocaine abuse: evidence for adverse effects on health and functioning. Psychiatr Ann. 1984; 14: 733–43
- Louie A K, Lannon R A, Ketter T A. Treatment of cocaine-induced panic disorder. Am J Psychiatry. 1989; 146: 40–4. [PUBMED], [INFOTRIEVE]
- Satel S L, Edell W S. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry. 1991; 148: 1708–11. [PUBMED], [INFOTRIEVE]
- Halikas J A, Crosby R D, Pearson V L, Graves N M. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clin Pharmacol Ther. 1997; 62: 89–105. [PUBMED], [INFOTRIEVE], [CSA]
- Brady K T, Sonne S C, Malcolm R J, et al, Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002; 10: 276–85. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lima A R, Lima M S, Soares B G, Farrell M. Carbamazepine for cocaine dependence. Cochrane Database Syst Rev. 2002, CD002023. [CSA]
- Kleber H D. Pharmacologic treatments for heroin and cocaine dependence. Am J Addict. 2003; 12, (suppl 2). S5–18. [PUBMED], [INFOTRIEVE]
- Hemby S E, Co C, Koves T R, Smith J E, Dworkin S I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology (Berl). 1997; 133: 7–16. [CROSSREF], [CSA]
- Berridge K C. Pleasures of the brain. Brain Cogn. 2003; 52: 106–28. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Franken I H. Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 563–79. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Berridge K C, Robinson T E. Parsing reward. Trends Neurosci. 2003; 26: 507–13. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lamb R J, Preston K L, Schindler C W, et al, The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther. 1991; 259: 1165–73. [PUBMED], [INFOTRIEVE]
- Schultz W, Tremblay L, Hollerman J R. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex. 2000; 10: 272–83. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Horvitz J C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 2000; 96: 651–6. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N D, Wang G J, Fowler J S, et al, Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997; 386: 830–3. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Allman J M, Hakeem A, Erwin J M, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci. 2001; 935: 107–17
- Braver T S, Barch D M, Gray J R, Molfese D L, Snyder A. Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cereb Cortex. 2001; 11: 825–36. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Erb S, Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci. 1999; 19, RC35.
- Elliott R, Dolan R J, Frith C D. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex. 2000; 10: 308–17. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ludwig A M, Wikler A, Stark L H. The first drink: psychobiological aspects of craving. Arch Gen Psychiatry. 1974; 30: 539–47. [PUBMED], [INFOTRIEVE]
- Shaham Y, Shalev U, Lu L, De, Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2003; 168: 3–20. [CROSSREF]
- Strange P G. The molecular biology of dopamine receptors. Stone T W. CNS neurotransmitters and neuromodulators: dopamine. Boca Rouge, FL, CRC. 1996; 65–87
- Xi Z X, Gilbert J, Campos A C, et al, Blockade of mesolimbic dopamine D(3) receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology (Berl). 2004; 176: 57–65. [CROSSREF]
- Vorel S R, Ashby C R, Jr., J Paul, M, et al, Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci. 2002; 22: 9595–603. [PUBMED], [INFOTRIEVE]
- Garcia-Ladona F J, Cox B F. BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction. CNS Drug Rev. 2003; 9: 141–58. [PUBMED], [INFOTRIEVE], [CSA]
- Hutchison K E, Wooden A, Swift R M, et al, Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology. 2003; 28: 1882–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boening J A. Neurobiology of an addiction memory. J Neural Transm. 2001; 108: 755–65. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- See R E, Fuchs R A, Ledford C C, McLaughlin J. Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci. 2003; 985: 294–307. [PUBMED], [INFOTRIEVE], [CSA]
- O'Brien C, Childress A, Ehrman R, Robbins S. Conditioning factors in drug abuse: can they explain compulsion?. J Psychopharmacol. 1998; 12: 15–22. [PUBMED], [INFOTRIEVE], [CSA]
- Breiter H C, Aharon I, Kahneman D, Dale A, Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron. 2001; 30: 619–39. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Childress A R, Mozley P D, McElgin W, Fitzgerald J, Reivich M, O'Brien C P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999; 156: 11–8. [PUBMED], [INFOTRIEVE]
- Kilts C D, Schweitzer J B, Quinn C K, et al, Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry. 2001; 58: 334–41. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Grant S, London E D, Newlin D B, et al, Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A. 1996; 93: 12040–5. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Due D L, Huettel S A, Hall W G, Rubin D C. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry. 2002; 159: 954–60. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hiroi N, White N M. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci. 1991; 11: 2107–16. [PUBMED], [INFOTRIEVE]
- Meil W M, See R E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res. 1997; 87: 139–48. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kalivas P W. Glutamate systems in cocaine addiction. Curr Opin Pharmacol. 2004; 4: 23–9. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kalivas P W, Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J Neurochem. 1998; 70: 1497–502. [PUBMED], [INFOTRIEVE]
- Carlezon W A, Jr., Nestler E J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci. 2002; 25: 610–5. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nestler E J. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 2002; 78: 637–47. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chao J, Nestler E J. Molecular neurobiology of drug addiction. Annu Rev Med. 2004; 55: 113–32. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen J, Kelz M B, Hope B T, Nakabeppu Y, Nestler E J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci. 1997; 17: 4933–41. [PUBMED], [INFOTRIEVE]
- Moratalla R, Elibol B, Vallejo M, Graybiel A M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 1996; 17: 147–56. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kelz M B, Nestler E J. deltaFosB: a molecular switch underlying long-term neural plasticity. Curr Opin Neurol. 2000; 13: 715–20. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kelz M B, Chen J, Carlezon W A, Jr., et al, Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 1999; 401: 272–6. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nestler E J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001; 2: 119–28. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Anton R F, Moak D H, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995; 19: 92–9. [PUBMED], [INFOTRIEVE], [CSA]
- Verheul R, van den, Brink W, Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol. 1999; 34: 197–222. [PUBMED], [INFOTRIEVE]
- Roberts J S, Anton R F, Latham P K, Moak D H. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res. 1999; 23: 1484–91. [PUBMED], [INFOTRIEVE], [CSA]
- Schwartz J M. Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. An evolving perspective on brain and behaviour. Br J Psychiatry Suppl. 1998; 38–44. [CSA]
- Perani D, Colombo C, Bressi S, et al, [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry. 1995; 166: 244–50. [PUBMED], [INFOTRIEVE]
- Rubin R T, Ananth J, Villanueva-Meyer J, Trajmar P G, Mena I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry. 1995; 38: 429–37. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wang G J, Volkow N D, Fowler J S, et al, Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci. 1999; 64: 775–84. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Adinoff B, Devous M DS, Best S M, George M S, Alexander D, Payne K. Limbic responsiveness to procaine in cocaine-addicted subjects. Am J Psychiatry. 2001; 158: 390–8. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N D, Wang G J, Fowler J S, et al, Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry. 1999; 156: 19–26. [PUBMED], [INFOTRIEVE]
- Maas L C, Lukas S E, Kaufman M J, et al, Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 1998; 155: 124–6. [PUBMED], [INFOTRIEVE]
- Schneider F, Habel U, Wagner M, et al, Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry. 2001; 158: 1075–83. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Garavan H, Pankiewicz J, Bloom A, et al, Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000; 157: 1789–98. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl). 2001; 158: 343–59. [CROSSREF], [CSA]
- Lu L, Shepard J D, Scott Hall F, Shaham Y. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev. 2003; 27: 457–91. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl). 1998; 137: 184–90. [CROSSREF], [CSA]
- Erb S, Hitchcott P K, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 2000; 23: 138–50. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000; 12: 292–302. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McFarland K, Davidge S B, Lapish C C, Kalivas P W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci. 2004; 24: 1551–60. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Harfstrand A, Fuxe K, Agnati L F, Benfenati F, Goldstein M. Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. Acta Physiol Scand. 1986; 128: 195–200. [PUBMED], [INFOTRIEVE]
- Deutch A Y, Bean A J. Colocalization in dopamine neurons. Bloom F E, Kupfer D J. Psychopharmacology: the fourth generation of progress. New York, Raven. 1995
- Barrot M, Marinelli M, Abrous D N, et al, The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci. 2000; 12: 973–9. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Marinelli M, Aouizerate B, Barrot M, Le, Moal M, Piazza P V. Dopamine-dependent responses to morphine depend on glucocorticoid receptors. Proc Natl Acad Sci U S A. 1998; 95: 7742–7. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Saal D, Dong Y, Bonci A, Malenka R C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003; 37: 577–82. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adinoff B, Iranmanesh A, Veldhuis J D, Fisher L. Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World. 1998; 22: 67–72
- Lovallo W R, Dickensheets S L, Myers D A, Thomas T L, Nixon S J. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res. 2000; 24: 651–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Coiro V, Vescovi P P. Effect of cigarette smoking on ACTH/cortisol secretion in alcoholic after short- and medium-term abstinence. Alcohol Clin Exp Res. 1999; 23: 1515–8. [PUBMED], [INFOTRIEVE], [CSA]
- Sapolsky R M. McEwen-induced modulation of endocrine history: a partial review. Stress. 1997; 2: 1–12. [PUBMED], [INFOTRIEVE]
- Kiefer F, Jahn H, Schick M, Wiedemann K. Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology (Berl). 2002; 164: 239–40. [CROSSREF], [CSA]
- Junghanns K, Backhaus J, Tietz U, et al, Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol. 2003; 38: 189–93. [PUBMED], [INFOTRIEVE]
- O'Malley S S, Krishnan-Sarin S, Farren C, Sinha R, Kreek J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl). 2002; 160: 19–29. [CROSSREF], [CSA]
- Schluger J H, Ho A, Borg L, Porter M, et al, Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res. 1998; 22: 1430–6. [PUBMED], [INFOTRIEVE], [CSA]
- Fillmore M T, Rush C R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 2002; 66: 265–73. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Petry N M, Bickel W K, Arnett M. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction. 1998; 93: 729–38. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Heyman G M, Dunn B. Decision biases and persistent illicit drug use: an experimental study of distributed choice and addiction. Drug Alcohol Depend. 2002; 67: 193–203. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Moeller F G, Dougherty D M, Barratt E S, et al, Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002; 68: 105–11. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rogers R D, Everitt B J, Baldacchino A, et al, Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999; 20: 322–39. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Grant S, Contoreggi C, London E D. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia. 2000; 38: 1180–7. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Meunier M, Bachevalier J, Mishkin M. Effects of orbital frontal and anterior cingulate lesions on object and spatial memory in rhesus monkeys. Neuropsychologia. 1997; 35: 999–1015. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bechara A, Damasio H, Tranel D, Anderson S W. Dissociation of working memory from decision making within the human prefrontal cortex. J Neuroscience. 1998; 18: 428–37
- Bechara A, Dolan S, Denburg N, Hindes A, Anderson S W, Nathan P E. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia. 2001; 39: 376–89. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ernst M, Grant S J, London E D, Contoreggi C S, Kimes A S, Spurgeon L. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry. 2003; 160: 33–40. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Adinoff B, Devous M D, Sr, Cooper D B, et al, Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. Am J Psychiatry. 2003; 160: 1892–4. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Volkow N D, Wang G J, Fowler J S, et al, Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry. 1997; 154: 50–5. [PUBMED], [INFOTRIEVE]
- Volkow N D, Hitzemann R, Wang G J, et al, Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry. 1992; 149: 1016–22. [PUBMED], [INFOTRIEVE]
- Volkow N D, Wang G-J, Fowler J S, et al, Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors. Am J Psychiatry. 1997; 154: 50–5. [PUBMED], [INFOTRIEVE]
- Goldstein R Z, Volkow N D, Wang G J, Fowler J S, Rajaram S. Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport. 2001; 12: 2595–9. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Paulus M P, Hozack N E, Zauscher B E, et al, Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology. 2002; 26: 53–63. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaufman J N, Ross T J, Stein E A, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci. 2003; 23: 7839–43. [PUBMED], [INFOTRIEVE]
- Adinoff B, Devous M D, Best S E, et al, Regional cerebral blood flow in female cocaine-addicted subjects following limbic activation. Drug Alcohol Depend. 2003; 71: 255–68. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sinha R. Probing stress-reward circuitry to understand cocaine craving and relapse. Paper presented at the 2003 annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December. 2003, [Abstract no. THAM13]. [CSA]
- London E D, Ernst M, Grant S, Bonson K, Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex. 2000; 10: 334–42. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volkow N D, Fowler J S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2001; 10: 318–25. [CROSSREF], [CSA]
- Krebaum S R, Jackley P K, Adinoff B. The Impulsive Relapse Questionnaire: development and validation. Drug Alcohol Depend. 2002; 66, (suppl). S96
- Robinson T E, Gorny G, Mitton E, Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse. 2001; 39: 257–66. [PUBMED], [INFOTRIEVE], [CSA]
- Rothman R B, Glowa J R. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol Neurobiol. 1995; 11: 1–19. [CSA]
- Preti A. Vanoxerine National Institute on Drug Abuse. Curr Opin Investig Drugs. 2000; 1: 241–51. [PUBMED], [INFOTRIEVE], [CSA]
- Carroll K M, Fenton L R, Ball S A, et al, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2004; 61: 264–72. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volpicelli J R, Alterman A I, Hayashida M, O'Brien C P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49: 876–80. [PUBMED], [INFOTRIEVE]
- O'Malley S S, Jaffe A J, Chang G, Schottenfeld R S, Meyer R E, Rounsaville B.. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry. 1992; 49: 881–7. [PUBMED], [INFOTRIEVE]
- Benjamin D, Grant E R, Pohorecky L A. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 1993; 621: 137–40. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brebner K, Childress A R, Roberts D C. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol. 2002; 37: 478–84. [PUBMED], [INFOTRIEVE]
- Shoptaw S, Yang X, Rotheram-Fuller E J, et al, Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry. 2003; 64: 1440–8. [PUBMED], [INFOTRIEVE]
- Brodie J D, Figueroa E, Dewey S L. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse. 2003; 50: 261–5. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Walsh S L, Geter-Douglas B, Strain E C, Bigelow G E. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther. 2001; 299: 147–58. [PUBMED], [INFOTRIEVE], [CSA]
- Johnson B A, Ait-Daoud N, Bowden C L, et al, Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003; 361: 1677–85. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kampman K M, Pettinati H, Lynch K G, et al, A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 2004; 75: 233–40. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kosten T R, Oliveto A, Sevarino K A, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend. 2002; 66: 173–80. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Montgomery A M, Rose I C, Herberg L J. The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmiss. J Neural Transm Gen Sect. 2001; 91: 1–11
- King G R, Xiong Z, Douglass S, Ellinwood E H. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J Pharmacology. 2000; 394: 97–101. [CROSSREF]
- Johnson B A, Roache J D, Javors M A, et al, Ondansetron for reduction of drinking among biologically predisposed alcoholic patients. JAMA. 2000; 284: 963–71. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gorelick D A, Gardner E L, Xi Z X. Agents in development for the management of cocaine abuse. Drugs. 2004; 64: 1547–73. [PUBMED], [INFOTRIEVE]
- De, Vries T J, Shaham Y, Homberg J R, et al, A cannabinoid mechanism in relapse to cocaine seeking. Nat Med. 2001; 7: 1151–4. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rada P V, Hoebel B G. Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it. Brain Res. 2001; 888: 60–5. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hajnal A, Mark G P, Rada P V, Lenard L, Hoebel B G. Norepinephrine microinjections in the hypothalamic paraventricular nucleus increase extracellular dopamine and decrease acetylcholine in the nucleus accumbens: relevance to feeding reinforcement. J Neurochem. 1997; 68: 667–74. [PUBMED], [INFOTRIEVE]
- Smith J E, Co C, Yin X, et al, Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev. 2004; 27: 841–50. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rasmussen T, Sauerberg P, Nielsen E B, et al, Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice. Eur J Pharmacol. 2000; 402: 241–6. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Szumlinski K K, Maisonneuve I M, Glick S D. Iboga interactions with psychomotor stimulants: panacea in the paradox?. Toxicon. 2001; 39: 75–86. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Glick S D, Maisonneuve I S. Mechanisms of antiaddictive actions of ibogaine. Ann N Y Acad Sci. 1998; 844: 214–26. [PUBMED], [INFOTRIEVE], [CSA]
- Mash D C, Kovera C A, Buck B E, Norenberg M D, Shapshak P, Hearn W L, Sanchez-Ramos J. Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann N Y Acad Sci. 1998; 844: 274–92. [PUBMED], [INFOTRIEVE], [CSA]